Release Date: 07/04/10 08:50 Summary: Bank Facility Terms Renegotiated and Extended Price Sensitive: Yes Download Document 116.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%